UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $29.49 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• UBS Asset Management increased its holdings in Sabra Healthcare REIT by 16.8% during the first quarter, owning approximately 1.7 million shares valued at $29.5 million.
• Several institutional investors also boosted their positions in Sabra Healthcare REIT, with D. E. Shaw & Co. increasing holdings by 749.3% and Nuveen Asset Management lifting theirs by 30.8% in the fourth quarter.
• Analysts have raised their price targets for Sabra Healthcare REIT, with JMP Securities and BMO Capital Markets setting targets at $22.00, indicating a consensus rating of Moderate Buy among investment analysts.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 16.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,687,977 shares of the real estate investment trust's stock after buying an additional 243,274 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned approximately 0.71% of Sabra Healthcare REIT worth $29,489,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in SBRA. Caxton Associates LLP bought a new stake in Sabra Healthcare REIT during the first quarter worth approximately $1,836,000. Presima Securities ULC boosted its stake in Sabra Healthcare REIT by 13.9% during the first quarter. Presima Securities ULC now owns 993,688 shares of the real estate investment trust's stock valued at $17,360,000 after buying an additional 121,323 shares in the last quarter. UniSuper Management Pty Ltd boosted its stake in Sabra Healthcare REIT by 3.2% during the first quarter. UniSuper Management Pty Ltd now owns 66,824 shares of the real estate investment trust's stock valued at $1,167,000 after buying an additional 2,100 shares in the last quarter. Uniplan Investment Counsel Inc. acquired a new stake in Sabra Healthcare REIT in the 1st quarter valued at about $3,294,000. Finally, Hancock Whitney Corp grew its stake in shares of Sabra Healthcare REIT by 1.9% in the 1st quarter. Hancock Whitney Corp now owns 209,923 shares of the real estate investment trust's stock worth $3,667,000 after purchasing an additional 3,888 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Stock Down 0.8%

SBRA traded down $0.15 during trading hours on Friday, hitting $18.71. 3,923,838 shares of the company's stock were exchanged, compared to its average volume of 2,041,152. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock's 50-day moving average is $18.73 and its two-hundred day moving average is $18.05. The stock has a market cap of $4.49 billion, a price-to-earnings ratio of 24.62, a PEG ratio of 1.50 and a beta of 0.88. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the company earned $0.36 earnings per share. The business's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Friday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. Sabra Healthcare REIT's dividend payout ratio (DPR) is 157.89%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. BMO Capital Markets upped their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a report on Monday, August 25th. JMP Securities increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. Truist Financial lifted their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a "hold" rating in a research note on Tuesday, September 2nd. Scotiabank lifted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. Finally, Wells Fargo & Company boosted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $20.83.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.